⚔️ Microsoft came for Apple

Microsoft wants to put AI into all of our hands | Carlyle went all in on Japan | [Finimize](   TOGETHER WITH     Hi {NAME}, here's what you need to know for May 22nd in 3:08 minutes.   💰 Words like "leverage" and "inverse" might sound like they're reserved for the folk that wear three-piece suits to work in a skyscraper. But join us for [The Insiders' Guide To Leveraged And Inverse ETF Trading]( on June 13th, and find out how accessible technical trading can be. [Grab your free ticket]( Today's big stories - Microsoft has been embedding AI into PCs, which could pull customers back from Macs - The five places where you might find opportunities as AI comes to blockchain – [Read Now]( - Carlyle proved that private equity is still big business in Japan An Apple A Day [An Apple A Day] What’s going on here? Microsoft unveiled its AI-powered PC on Monday, aiming to [take]( a bite out of Apple's business. What does this mean? Microsoft’s Copilot+ PCs will feature new Qualcomm chips that promise blazing speed, all-day battery life, cooler temperatures, and the ability to handle some AI tasks offline. That could leave Apple in its dust, with PCs that are 58% faster than the MacBook Air M3. To pull this all off, Microsoft made two big moves. For one, it optimized Windows systems to run on the latest and most efficient chips, which are more like the type used in smartphones than the usual Intel ones. For another, Microsoft added a dedicated chip component that can process AI features from within the laptop itself, instead of using the cloud. Why should I care? Zooming out: The deal’s a win-win. Microsoft is relying on Qualcomm’s energy-efficient chips – produced in partnership with British chip company Arm – to power AI models and improve the Windows franchise. For Qualcomm, that’s a chance to showcase its mobile phone tech’s suitability for AI-powered devices. Morgan Stanley certainly sees this partnership sticking around: the big bank predicts that 14% of all Windows PC shipments will feature Arm systems as soon as 2026, up from, well, 0% last year. The bigger picture: It pays to be first. Microsoft’s leading the Big Tech pack when it comes to AI. The company hinted that its AI agent, capable of seeing and speaking, will soon be in smart speakers, phones, and even VR headsets. Plus, Microsoft’s bet on OpenAI is paying off. With the ChatGPT-creator's advanced language models enhancing Copilot AI, Microsoft can now better compete with Google and Apple. So naturally, Microsoft wants to capitalize on its early lead by creating AI products that everyday consumers will pay for. Right now, it seems the next phase of the AI race is not about world-changing software, but rolling out portable, AI-first products. You might also like: [This is AI’s most underrated opportunity, and the eight stocks at the center of it.]( Copy to share story: [( 🙋 [Ask a question](mailto:questions@finimize.com?body=Ask us a question: Where are you writing from? Let us know and we'll mention it when we reply.&noapp=true&subject=An Apple A Day&utm_campaign=daily-global-22-05-2024&utm_source=email) Analyst Take AI Meets Blockchain, And Where To Find Opportunities [AI Meets Blockchain, And Where To Find Opportunities]( By Jonathan Hobbs, CFA, Analyst Nvidia’s not the only [AI investing play]( out there – not by a mile (even if its share price does suggest otherwise). And the one that’s got my attention now is in crypto. See, eventually the blockchain will meet AI, and there will be some pretty good opportunities when it does. That’s today’s Insight: [blockchain meets AI, and how to invest in that.]( [Read or listen to the Insight here]( SPONSORED BY BIOSTEM Discover the cutting-edge of medical tech [Biostem (OTC:BSEM)]( is developing cutting-edge regenerative medicine products. In everyday terms, that means the company’s finding scientific treatments that make cells regenerate, so humans can self-heal their wounds. That’s no far-off sci-fi idea: BSEM’s innovative allograft tech helped bring in [$41.9 million of revenue]( last quarter, nearly 71 times higher than a year ago. Gross profit was 95% of that: $39.7 million. BSEM also brought McCoy Clinical Consulting into the fold, tasking the firm with leading trials on [ulcer products]( for vein conditions and diabetes complications to demonstrate [real-world capabilities](. After a quarter like that, you can see why Zacks Small Cap Research recently increased BSEM’s [stock price estimate]( to $22. If you want to explore the cutting-edge of science, [meet BSEM](. [Find Out More]( This content is for US investors only, if you are not a US investor please ignore this content. This content is a paid advertisement for BioStem (OTC:BSEM) from Sideways Frequency and Finimize. This is not Finimize editorial content. Finimize received a fixed fee for producing, hosting and promoting this content on behalf of BioStem (OTC:BSEM), totalling $10,000. Other than the compensation received for this service, Finimize and its principals are not affiliated with either Sideways Frequency or BioStem (OTC:BSEM). Finimize and its principals have no ownership in BioStem (OTC:BSEM). The content on this page should not be taken as advice, an endorsement, or a recommendation from Finimize and its principals to buy or sell any security. Finimize and its principals have not evaluated the accuracy of any claims made on this page. Finimize and its principals recommend that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky and capital is at risk. Past performance is not indicative of future results. When you support our sponsors, you support us. Thanks for that. If you want your brand featured here, [get in touch.]( Land Of The Raising Sums [Land Of The Raising Sums] What’s going on here? Asset manager Carlyle [raised]( billions for the biggest-ever Japan-focused private equity fund. What does this mean? Private equity firms have generally struggled to raise cash in today’s “will-it-or-won’t-it recession” economy. But it seems investors will make an exception for Japan: the value of management buyouts in the country hit a record high last year. In fact, Carlyle has managed to raise 430 billion yen ($2.8 billion) for its fifth Japanese buyout fund – 70% more than it racked up in its last round during 2021. And there’s a reason why the asset manager needed to line its coffers: Carlyle recently announced it was buying KFC Japan, spending 135 billion yen ($863 million) to get its fingers – licked, presumably – into the country’s food industry. Why should I care? Zooming out: So this is love. Investors’ fascination with Japan is, in part, down to the government’s efforts to make the country’s companies more profitable and lucrative for shareholders. But on top of that, Japan has the lowest interest rates of any developed country, with rates only recently poking their head above zero. That not only supports the country’s economic recovery, but also makes borrowing cheap. So while the high interest rates of most other major markets are making it expensive for firms to pull off hefty purchases, Japan is looking a lot more affordable. The bigger picture: Oh Blighty. The UK’s companies have been on shopping lists, too: takeover activity in the country recently hit its highest level since 2018. Now, the UK’s interest rates are high, sure, but that’s outweighed by the country’s cheap company valuations. So recently, firms have been making opportunistic bids on companies listed on the London Stock Exchange, with analysts speculating that they may relist the companies stateside where they’d likely fetch a higher valuation. You might also like: [Why BlackRock is big on Japan.]( Copy to share story: [( 🙋 [Ask a question](mailto:questions@finimize.com?body=Ask us a question: Where are you writing from? Let us know and we'll mention it when we reply.&noapp=true&subject=Land Of The Raising Sums&utm_campaign=daily-global-22-05-2024&utm_source=email) 💬 Quote of the day "Be brave enough to live life creatively. The creative place where no one else has ever been." – Alan Alda (an American actor and author) [Tweet this]( Your cheat sheet for choosing a trading platform There are nearly as many trading platforms as there are stocks nowadays. So it’s tough to weed through them all – but if you want to find a platform with [the sharpest tools](, the [best benefits](, and the [fewest hidden fees or fine print](, you’ll need to plow through one by one. Or not. [Our guide]( to finding the right trading platform details the components that you’ll want to look for, the factors that can set you up for an optimum experience, and any red flags to be aware of. Think of it as your [cheat sheet for vetting platforms](, so you can streamline your search. Or if you want an even easier route, we included [an overview of IG’s platform]( – you might just find it sticks. [Read The Guide]( 👀 The Bill Gross Problem It’s strange days when the “[bond king](” doesn’t like doesn’t like America’s benchmark bond. Bill Gross isn't exactly fond of the[10-year Treasury or other longer-dated bonds]( right now, but you can’t blame the guy: the numbers aren't pretty. [Let's find out if Gross has a point about bonds.]( [Read The Quicktake]( 🎯 On Our Radar 1. Use nicotine, win an iPad. This nicotine pouch company has a [controversial new rewards scheme](. 2. Bitcoiners and gold bugs both believe their favorite investment towers above the rest. Here's why [mixing the two could spell good news]( for your portfolio.* 3. Keep on swimming. Meet the grandmother [who swam 30 miles]( through shark-infested waters. 4. Today’s top companies won't necessarily rule the roost tomorrow. [Brush up your investing skills]( with this rundown.** 5. Bless you. Here’s how a spoonful of honey could keep those [seasonal allergies away](. Stocks is a derivative product offered by Change Securities B.V. that replicates the performance of your favourite companies’ shares - full or fractional.* See important disclosures [here](. ** When you support our sponsors, you support us. Thanks for that. 🌍 Finimize Live 🤩 Coming up soon... All events in UK time. 💰[The Insiders Guide To Leveraged & Inverse ETF Trading](: 5pm, June 13th 🔒 [How to Future Proof Your Finances In 5 Years](: 5pm, June 18th 🏔️ [Gaining An Edge Beyond ETFs](: 8pm, June 19th 🤑 [How AI Can Help You Invest Like The Wealthy](: 5pm, June 25th 🚀 [2024 Modern Investor Summit](: 2pm, December 3rd ❤️ Share with a friend Thanks for reading {NAME}. If you liked today's brief, we'd love for you to share it with a friend. You stay classy, {NAME} 😉 We’d love to hear your thoughts. [Give feedback]( Want to advertise with us too? [Get in touch]( Image Credits: Image credits: Dall-e | Dall-e Preferences: [Update your email]( or [change preferences]( [View in browser]( [Unsubscribe]( from all Finimize Emails 😴 Crafted by Finimize Ltd. | 280 Bishopsgate, London, EC2M 4AG All content provided by Finimize Ltd. is for informational and educational purposes only and is not meant to represent trade or investment recommendations. You signed up to this mailing list at finimize.com or through one of our partners. © Finimize 2021 [View Online](